Supplementary Figure S3 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

<p>Structural Analyses of sunitinib, regorafenib and ripretinib in T670I-mutant KIT</p>

Gardado en:

Detalles Bibliográficos
Autor Principal:	Johanna Falkenhorst (15039017) (author)
Outros autores:	Philipp Ivanyi (22348006) (author), Tom Schulz (22348009) (author), Rainer Hamacher (15043827) (author), Bernd Kasper (22348012) (author), Peter Hohenberger (15321510) (author), Christoph K.W. Deinzer (22348015) (author), Daniel Pink (20657554) (author), Benjamin S. Fletcher (22348018) (author), Valerie Haller (22348021) (author), Yasmin Optaczy (22348024) (author), Susanne Grunewald (22348027) (author), Daniel Rauh (14939846) (author), Adrian Mariño-Enríquez (22348030) (author), Thomas Mühlenberg (15076563) (author), Peter Reichardt (15321525) (author), Sebastian Bauer (15036426) (author)
Publicado:	2025
Subjects:	Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Clinical Trial Results Phase II clinical trials Drug Targets Protein kinase & phosphatase drug targets Liquid Biopsy Preclinical Models In vitro models of cancer Sarcomas Soft-tissue sarcoma
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares